This is an excerpt of a 1,028-word article in the September 14, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. WHILE SOME LABS CELEBRATE THE PERCEIVED FLEXIBILITY thatĀ comes from not having to get anĀ emergency use authorization (EUA) forĀ COVID-19 laboratory-developed testsĀ (LDTs), there is a potential […]
- Lab Regulatory Update
Will HHS Ruling on COVID-19 LDTs Be Good or Bad for Lab Reimbursement?
COVID-19 LDTs Decision Could Be Negative for Reimbursement
- By Robert Michel
- > From the Volume XXVII No. 13 - September 14, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, clinical laboratory test, clinical labs, COVID-19, COVID-19 test, COVID-19 test reimbursement, FDA Emergency Use Authorization (EUA), lab industry, lab test, lab testing, lab tests, Laboratory Developed Test (LDT), laboratory industry, laboratory test, laboratory testing, laboratory tests
